Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Otsuka Of Japan Opens Intermediaries Plant In India

This article was originally published in PharmAsia News

Executive Summary

Japan's Otsuka Pharmaceutical opened a plant in India to produce antibiotic intermediaries for sale to local Indian drug makers. The $48 million plant is capable of producing 500 tons of the intermediaries to meet a growing demand by Indian drug makers in the process of a global expansion. Until the Indian plant opened, with initial production set at 300 tons, Otsuka had been supplying Indian drug makers from production facilities in Japan. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts